Advanced Filters
noise

Carcinoma Clinical Trials

A listing of Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 6,091 clinical trials
M Mohamed AbdElmoniem

Demographics of Lung Cancer in Females

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.

years of age Female Phase N/A
Y Yu-Hung Chen, M.D.

The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

Lung cancer is currently the leading cause of cancer-related mortality worldwide, and the dominant histopathology is non-small cell lung cancer (NSCLC). Although many new targeted and immunomodulation therapies have emerged, not all patients are responsive to novel therapeutics. A more reliable and accurate risk stratification model to predict the treatment …

20 years of age All Phase N/A
M Mau Ern Poh, MBBS

Biomarker Discovery in Lung Cancer - Malaysia

This study aims to Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.

30 years of age All Phase N/A
S Shun Lu, Dr.

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Neoadjuvant immunotherapy has become the standard perioperative treatment in lung cancer, but its effective predictive biomarkers are lacking. A small cohort reported that homologous recombination deficiency (HRD) can be used as a reliable biomarker to predict the efficacy of neoadjuvant immunotherapy, but the findings need to be validated in larger …

18 - 80 years of age All Phase N/A
K Kang Hu, MD

Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules

Research objective: To explore the clinical application effect of multi-omics detection based on flow cytometry analysis, single-cell data and images combined with clinical features in differentiating the benign and malignant nature of pulmonary nodules and the early diagnosis of lung cancer

years of age All Phase N/A
G Giuseppe Marulli, MD

Robotic Assisted Major Lung Resection in Elderly Patients

The study is a retrospective observational study. The study is designed to be multicentric and it will analyze medical records from selected patients that underwent major lung resection using DaVinci surgical platform performed in the participating centers. There are no risks for the patients, as this is a retrospective data …

18 years of age All Phase N/A
S Saskia van Heumen, MSc

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

The overall purpose of this study is to characterise the clinical safety and performance of the Creo Medical MicroBlate™ Flex AB1 instrument in patients with pathologically confirmed malignancy eligible for surgical resection of their nodule, receiving bronchoscopic ablation prior to surgery.

18 years of age All Phase N/A

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using the Thyroid GuidePx® test in patients with papillary thyroid carcinoma.

18 years of age All Phase N/A
L Lian Yang

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.

18 years of age All Phase N/A
G Guangying Zhu, M.D.

The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy

Definitive radiotherapy is one of the important methods for inoperable locally advanced lung cancer. The recommended dose for definitive radiotherapy is 60-70Gy, and the optimal dose is still uncertain. Residual lesion after radiotherapy is a risk factor for recurrence. High doses to targeted tumor areas can effectively improve the local …

18 years of age All Phase N/A

Simplify language using AI